EOLS
#2834
Evolus, Inc. - Common Stock
7.7 5 USD
0.00%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+0.26%
Variación mensual
-1.90%
Variación en los últimos 6 meses
+82.35%
Cambio anual
+26.02%
Cierres anteriores
7.7 3
Open
7.7 6
Mínimo
7.6 7
Máximo
7.8 3
Financials
- Market Capitalization 511.89 M
- Employee 353
- Founded 2012
- CEO David Moatazedi
- Website www.evolus.com
- Headquarter Delaware, United States
- FIGI BBG005CX4HK8
- Industry Fabricantes de medicamentos — especializados y genéricos
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-8.31
Relación precio/flujo de caja
1.44
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2718 |  IRWD Ironwood Pharmaceuticals, Inc. - Class A Common Stock | 3.76 USD | -1.57% | +3.30% | -8.29% | +129.27% | 621.30 M USD | ||
| 2733 |  AQST Aquestive Therapeutics, Inc. - Common Stock | 4.81 USD | +0.63% | +4.11% | +2.34% | -27.01% | 603.71 M USD | ||
| 2850 |  TLRY Tilray Brands, Inc. - Common Stock | 3.36 USD | -5.08% | -10.16% | -15.79% | +84.62% | 496.57 M USD | ||
| 2872 |  EVO Evotec SE - American Depositary Shares each representing 1/2 of | 1.37 USD | -10.46% | -20.81% | -18.45% | -67.92% | 487.11 M USD |